BioSpace News Archive

A new Cohen Clinic offering accessible, high-quality mental healthcare will open in the Last Frontier in early 2020

Powering Precision Health (PPH), the internationally-acclaimed Summit focused on precision health and the latest in biomarker research, today announced much-anticipated details for its 2019 Summit, which will take place in Barcelona on November 19.

SaVida Health, a leader in outpatient medication-assisted treatment (MAT) for opioid and alcohol addiction, will open a new treatment center in Staunton, Virginia on September 30, 2019

iTether Technologies, Inc. (iTether), a Phoenix-based outpatient care coordination and patient engagement platform, has launched a partnership with Healthwise, a Boise, Idaho-based leader in evidence-based health education, technology and services.

As major drug makers from Johnson & Johnson to Purdue Pharma face mounting legal challenges for their role in the US opioid epidemic, suppliers of the $94 billion global pharmaceutical packaging industry are using innovation to comply with regulations aimed at preventing such crises in the future.

The Hilb Group, LLC (“THG”) announced today the acquisition of North Carolina-based Josh Williams Enterprises, Inc. d/b/a WNC Health Insurance (“WNC”). The transaction became effective September 1, 2019.

Centinel Spine, LLC, the largest privately-held spine company focused on anterior column reconstruction, today celebrated thirty years of clinical use of the prodisc total disc replacement technology.

Move reinforces commitment to providing better access to flood protection across North America

UroGen Pharma Ltd. (Nasdaq: URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of uro-oncology, today announced updated findings from the UGN-101 Phase 3 OLYMPUS Trial in patients with low-grade upper tract urothelial cancer (LG UTUC), as well as initial CR data from the UGN-102 Phase 2b OPTIMA II Trial in patients with intermediate risk low-grade non-muscle invasive bladder cancer (LG NMIBC).

EXOSOME SCIENCES, a subsidiary of Aethlon Medical, Inc. (Nasdaq: AEMD), announced a research collaboration to identify and characterize exosomes derived from patients with solid tumors such as pancreas cancer, as well as from families with genetically high risk of developing cancer.